| Name | Title | Contact Details |
|---|
Medical Art Prosthetics LLC is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
St. Vincent's Medical Center is a Bridgeport, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
CaroMont Health in Gastonia, North Carolina is a regional, independent, not-for-profit health care system, and nationally recognized “value-based” healthcare provider. CaroMont Health is the only hospital in the region named by Thomson-Reuters as a 100 Top Hospital for quality care, and is one of only two HealthGrades’ Clinical Excellence recipients in North Carolina. CaroMont Health System includes CaroMont Regional Medical System with 435-beds; Courtland Terrace, a 96-bed skilled nursing facility; Gaston Hospice, which includes the 12-bed Robin Johnson House inpatient facility; and CaroMont Medical Group, a network of 45 primary and specialty physician offices. The CaroMont Heart Center provides a full range of life-saving cardiac care, including open heart surgery. Additionally, the CaroMont Cancer Center provides advanced 3-D radiation treatment planning and chemotherapy. An expansive, surgical suite offers the latest advancements such as stereotactic technology, which utilizes computer simulation, microscopic surgery and x-ray images to achieve pinpoint accuracy. CaroMont also offers a level III neonatal intensive care unit for high risk infants and a pre-adolescent psychiatric center. CaroMont Health is proactively engaged in achieving its vision: To be a nationally recognized leader and valued partner in promoting individual health and vibrant communities. CaroMont Health employs 3,800 healthcare professionals, including a medical staff of 455.
Lane Frost Health and Rehabilitation Center is a Hugo, OK-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.